Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Actin Treadmilling01:18

Actin Treadmilling

9.8K
Actin filaments undergo polymerization and depolymerization from either end. The polymerization and depolymerization rates depend on the cytosolic concentration of free G-actins. The polymerization rate is generally higher at the plus or barbed end, while the depolymerization rate is higher at the minus or pointed end. At a steady state, critical concentration describes the concentration of free G-actin monomers at which the polymerization rate at the plus end is equal to that of the...
9.8K
Self-Efficacy01:29

Self-Efficacy

239
Self-efficacy is the belief in one's capacity to organize and execute actions necessary to manage prospective situations. This belief significantly influences how individuals approach goals, tasks, and challenges across different domains of life.Psychological and Educational ImpactsIndividuals with strong self-efficacy are more resilient in the face of difficulties. They are more likely to adopt effective problem-solving strategies, persist through obstacles, and regulate emotions such as...
239
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

435
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
435
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Clinical Trials01:16

Clinical Trials

10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K
Random Error01:04

Random Error

9.9K
Random or indeterminate errors originate from various uncontrollable variables, such as variations in environmental conditions, instrument imperfections, or the inherent variability of the phenomena being measured. Usually, these errors cannot be predicted, estimated, or characterized because their direction and magnitude often vary in magnitude and direction even during consecutive measurements. As a result, they are difficult to eliminate. However, the aggregate effect of these errors can be...
9.9K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Probability of a timely vocal response in mother-infant interaction and later psychiatric diagnosis: A case-control study.

PloS one·2026
Same author

Endotype-informed therapy and effects on illness perception and psychological health in patients with chest pain and no obstructive coronary artery disease.

European heart journal. Quality of care & clinical outcomes·2026
Same author

Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort study.

The Lancet. Respiratory medicine·2026
Same author

External validation of the BAN-ADHF diuretic-resistance score in the DAPA-RESIST clinical trial.

British journal of clinical pharmacology·2026
Same author

Non-invasive endotyping improves treatment satisfaction and prescribing appropriateness in patients with angina and no obstructive coronary artery disease.

Open heart·2026
Same author

Autism and attachment disorder symptoms in the general population: Prevalence, overlap, and burden.

Developmental child welfare·2026
Same journal

Cardiometabolic Health of Low- and Higher-Income Adults in the United States, 2009-2023.

American heart journal·2026
Same journal

Moving Beyond Technical Capability to Regulatory Integration for Digital Health Technology Devices-Brief Communication from the Cardiovascular Sciences Research Consortium.

American heart journal·2026
Same journal

THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

American heart journal·2026
Same journal

DOAC Score Among Patients Receiving Vitamin K Antagonists.

American heart journal·2026
Same journal

Considerations for Using Atrial Fibrillation Burden as a Surrogate Endpoint A Report from the Cardiovascular Sciences Research Consortium.

American heart journal·2026
Same journal

Prognostic Impact of Combined Inflammatory Markers in Patients Undergoing Percutaneous Coronary Intervention.

American heart journal·2026
関連記事をすべて見る

関連する実験動画

Updated: Feb 15, 2026

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

2.0K

ランダム化され,コントロールされた試験における有効性の評価のためのエクササイズ・トレッドミルのテスト.

Andrew Morrow1, Robin Young2, George R Abraham3

  • 1British Heart Foundation Glasgow Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom (UK).

American heart journal
|February 13, 2026
PubMed
まとめ
この要約は機械生成です。

運動トレッドミルのテストでは,ジボテンタンがマイクロ血管性アンギナに対する運動期間を改善することを示しませんでした. 運動テストの改善は,治療に関係なく,時間の経過とともに発生し,女性の性別と関連していました.

キーワード:
閉塞された冠動脈がない胸痛.エンドセリン受容体のアンタゴニストである.運動テスト 運動テスト微小血管性アンギナ (マイクロ血管性アンギナ) とは薬剤療法による薬剤療法治験のエンドポイントである.

さらに関連する動画

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.8K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.2K

関連する実験動画

Last Updated: Feb 15, 2026

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

2.0K
Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.8K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.2K

科学分野:

  • 心臓病学 心臓病学
  • クリニック・トライアル 臨床試験
  • 薬理学 薬理学とは

背景:

  • 運動トレッドミルのテストは,機能能力と心筋不全の標準的な測定であり,しばしば臨床試験のエンドポイントとして使用されます.
  • 微血管性アンギナは,機能能力に影響を与える状態であり,疾患を改変する治療法は研究中です.
  • 選択性エンドセリンA受容体抗体であるジボテンタンは,マイクロ血管性アンギナの治療の可能性について評価されました.

研究 の 目的:

  • マイクロ血管性アンギナ患者における機能能力とアンギナ症状の改善におけるジボテンタンの有効性を評価する.
  • 試験内の連続した試験訪問における運動期間の変化を分析する.
  • 試験内での運動期間変化に関連する要因を特定する.

主な方法:

  • ランダム化,ダブルブラインド,クロスオーバー試験の設計が採用されました.
  • 参加者はジボテンタン (10 mg/日12週間) またはプラセボを投与された.
  • 主なアウトカム指標は,エクササイズトレッドミルのテストで評価された運動期間でした.

主要な成果:

  • ジボテンタンは,プラセボと比較して,運動期間やアンギナ症状を有意に改善しませんでした.
  • 運動テストの期間は,治療に関係なく,すべての参加者の連続的な研究訪問を通じて徐々に増加しました.
  • 運動期間におけるこの改善は,女性の性別と有意に関連していた (p=0.002).

結論:

  • 運動トレッドミルのテストは,ランダム化試験における有効性の客観的なエンドポイントとして制限がある可能性があります.
  • 時間の経過とともに観察された運動時間の改善は,薬物のみに起因するものではなく,学習または適応効果を示唆しています.
  • 女性の性別は,試験内で運動期間改善に関連する要因として特定されました.